Wells Fargo Upgrades Acelyrin Inc (SLRN) to Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts SLRN Hot Sheet
Price: $2.27 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 1
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 1
Join SI Premium – FREE
Wells Fargo analyst Derek Archila upgraded Acelyrin Inc (NASDAQ: SLRN) from Equal Weight to Overweight with a price target of $13.00.
For an analyst ratings summary and ratings history on Acelyrin Inc click here. For more ratings news on Acelyrin Inc click here.
Shares of Acelyrin Inc closed at $4.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Upgrades Lyntris (LYNX) to Strong Buy
- Precigen Inc. (PGEN) PT Raised to $12 at Citizens on 'Stellar Quarter for PAPZIMEOS'
- UBS Downgrades PagSeguro (PAGS) to Neutral
Create E-mail Alert Related Categories
UpgradesRelated Entities
Wells Fargo, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
